Zhihao Xu

5PUBLICATIONS
61CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyInnate immunityCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 03, 2021
ASC deglutathionylation is a checkpoint for NLRP3 inflammasome activation.

Shuhang Li, Linlin Wang, Zhihao Xu

|Jan 12, 2021
Homotypic CARD-CARD interaction is critical for the activation of NLRP1 inflammasome.

Zhihao Xu, Ying Zhou, Muziying Liu

Pageof 1